This HAS-BLED calculator scores major bleeding risk in patients on (or being considered for) anticoagulation in atrial fibrillation, and returns the published bleeding rate for the score.










–

The Caution Half of the AF Conversation

Read it alongside the stroke side: our CHA2DS2-VASc Calculator. Part of our Health Calculators collection.

Worked Example

  • 78-year-old with uncontrolled hypertension on daily ibuprofen: age (1) + HTN (1) + drugs (1) = score 3 → ≈ 3.74 major bleeds/100 patient-years, HIGH — and note both extra points are modifiable: control the BP, swap the NSAID, and the score falls to 1
  • The acronym is the checklist: Hypertension, Abnormal renal/liver (1 each), Stroke, Bleeding, Labile INR, Elderly, Drugs/alcohol (1 each) — maximum 9
  • Scores 6–9 exist on paper; the derivation cohort had so few such patients that no trustworthy rate is published — the tool says so rather than inventing one

Score Discipline

  • HAS-BLED was derived for warfarin-era AF care; it still stratifies risk on DOACs, though the labile-INR item is warfarin-specific.
  • Dynamic beats static: re-score after medication changes, BP control and alcohol counseling — the score is a to-do list wearing a number.
  • Pair-decision rule of thumb: high HAS-BLED + high CHA₂DS₂-VASc → fix modifiables, choose the safer agent, schedule earlier review — don’t simply deny stroke prevention.
  • Bleeding rates quoted are major bleeds per 100 patient-years from the Pisters 2010 derivation, the table every guideline reproduces.

Related Tools

Frequently Asked Questions

How is the HAS-BLED score calculated?

One point each for: hypertension (SBP > 160), abnormal renal function, abnormal liver function, prior stroke, bleeding history/predisposition, labile INR, age > 65, interacting drugs (antiplatelets/NSAIDs), and alcohol excess — maximum 9. This calculator sums them and reports the published bleeding rate.

What HAS-BLED score is high risk?

≥ 3 is classified high risk (≈ 3.74+ major bleeds per 100 patient-years in the derivation cohort, rising to 8.70 at 4 and 12.50 at 5). “High” means caution, correction of modifiable factors and closer review — guidelines are explicit that it should not by itself deny anticoagulation.

What are the bleeding rates by score?

Pisters 2010 (bleeds per 100 patient-years): 0 → 1.13, 1 → 1.02, 2 → 1.88, 3 → 3.74, 4 → 8.70, 5 → 12.50. Scores 6–9 were too rare in the cohort for reliable rates — reported here as high risk without an invented number.

Which HAS-BLED factors can be changed?

Most of them: blood-pressure control, stopping or substituting NSAIDs/unnecessary antiplatelets, alcohol reduction, and INR stabilization (or switching from warfarin to a DOAC where appropriate). Only age, prior stroke and established organ damage are fixed. That modifiability is the score’s main clinical point.

Should a high HAS-BLED stop anticoagulation?

By itself, no. Stroke and bleeding risks usually rise together (age and hypertension feed both scores); net-benefit analyses favor treating the stroke risk while actively managing bleeding factors. The decision is individualized and clinical — this tool is educational.

Is this HAS-BLED calculator medical advice?

No — it’s an educational implementation of a published score. Anticoagulation decisions belong with the treating clinician who knows the full picture.